Abstract
While a longstanding body of evidence has suggested that nitric oxide plays a key role in maintaining vascular tone, work over the last decade has indicated that nitric oxide also is an important messenger in the central nervous system. Due to the extremely labile nature of this molecule, quantitation in bulk brain tissue is problematic. Indirect methods of analysis, therefore, have been developed, with the use of microdialysis technology for sample collection. To probe the physiologic and pharmacologic importance of nitric oxide, a variety of nitric oxide synthase inhibitors also have been identified and are amenable to quantitative analysis by standard chromatographic techniques in brain tissue microdialysate. The use of the microdialysis approach for the combined purpose of measuring concentrations of nitric oxide synthase inhibitors at the site of action and changes in nitric oxide content at that site illustrates the power of microdialysis in studies designed to elucidate the linkage between drug concentration (pharmacokinetics) and drug action (pharmacodynamics). This chapter is intended to describe the experimental design, procedural issues, and types of data associated with the use of brain microdialysis to explore the role of nitric oxide in central nervous system pharmacokinetics and pharmacodynamics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Viswanathan CT, Bansal S, Booth B et al (2007) Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res 24:1962–1973
Holford NH, Sheiner LB (1981) Pharmacokinetic and pharmacodynamic modeling in vivo. Crit Rev Bioeng 5:273–322
Mager DE, Jusko WJ (2008) Development of translational pharmacokinetic-pharmacodynamic models. Clin Pharmacol Ther 83:909–912
Zhou Q, Gallo JM (2011) The pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinic. AAPS J 13:111–120
Höcht C, Opezzo JA, Bramuglia GF et al (2006) Application of microdialysis in clinical pharmacology. Curr Clin Pharmacol 1:163–183
Helmy A, Carpenter KL, Hutchinson PJ (2007) Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs. Curr Med Chem 14:1525–1537
Blakeley J, Portnow J (2010) Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development. Expert Opin Drug Metab Toxicol 6:1477–1491
Barbosa RM, Lourenço CF, Santos RM et al (2008) In vivo real-time measurement of nitric oxide in anesthetized rat brain. Methods Enzymol 441:351–367
Moncada S, Palmer RM, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709–1715
Bauer V, SotnÃková R (2010) Nitric oxide—the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 29:319–340
Stokes GS (2006) Nitrates as adjunct hypertensive treatment. Curr Hypertens Rep 8:60–68
Hara S, Mukai T, Kurosaki K, Mizukami H et al (2004) Different response to exogenous L-arginine in nitric oxide production between hippocampus and striatum of conscious rats: a microdialysis study. Neurosci Lett 366:302–307
Gören MZ, Aricioglu-Kartal F, Yurdun T et al (2001) Investigation of extracellular L-citrulline concentration in the striatum during alcohol withdrawal in rats. Neurochem Res 12:1327–1333
Nowak P, Brus R, Oswiecimska J et al (2002) 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. An in vivo microdialysis and voltammetric study. J Physiol Pharmacol 53:251–263
Pepicelli O, Raiteri M, Fedele E (2004) The NOS/sGC pathway in the rat central nervous system: a microdialysis overview. Neurochem Int 45:787–797
Hong SK, Jung IS, Bang SA et al (2006) Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. Neurosci Lett 409:220–223
Chalimoniuk M, Langfort J (2007) The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 50:821–833
Raimondi L, Alfarano C, Pacini A et al (2007) Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats. Br J Pharmacol 150:1003–1010
Llansola M, Hernandez-Viadel M, Erceg S et al (2009) Increasing the function of the glutamate-nitric oxide-cyclic guanosine monophosphate pathway increases the ability to learn a Y-maze task. J Neurosci Res 87:2351–2355
Li S, Wang W, Wang C et al (2010) Possible involvement of NO/NOS signaling in hippocampal amyloid-β production induced by transient focal cerebral ischemia in aged rats. Neurosci Lett 470:106–110
Saulskaya NB, Fofonova NV, Sudorgina PV (2010) Activation of the noergic system of the nucleus accumbens on presentation of contextual danger signals. Neurosci Behav Physiol 40:907–912
Kalinchuk AV, McCarley RW, Porkka-Heiskanen T et al (2011) The time course of adenosine, nitric oxide (NO), and inducible NO synthase in the brain with sleep loss and their role in the non-rapid eye movement sleep homeostatic cascade. J Neurochem 116:260–272
Koizumi H, Fujisawa H, Suehiro E et al (2011) Neuroprotective effects of Ebselen following forebrain ischemia: involvement of glutamate and nitric oxide. Neurol Med Chir (Tokyo) 51:337–343
Karlsson GA, Chaitoff KA, Hossain S et al (2007) Modulation of cardiovascular responses and neurotransmission during peripheral nociception following nNOS antagonism within the periaqueductal gray. Brain Res 1143:150–160
Zelinski LM, Ohgami Y, Chung E et al (2009) A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice. J Pain 10:167–172
Toda N, Kishioka S, Hatano Y et al (2009) Modulation of opioid actions by nitric oxide signaling. Anesthesiology 110:166–181
Abdel-Zaher AO, Abdel-Rahman MS, Elwasei FM (2010) Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance and dependence in mice. Neurochem Res 35:1557–1565
Horton TL, Pollack GM (1991) Enterohepatic recirculation and renal metabolism of morphine in the rat. J Pharm Sci 80:1147–1152
Dagenais C, Zong J, Ducharme J et al (2001) Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds. Pharm Res 18:957–963
Dagenais C, Graff CL, Pollack GM (2004) Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochem Pharmacol 67:269–276
Kalvass JC, Olson ER, Cassidy MP et al (2007) Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther 323:346–355
Chen C, Pollack GM (1997) Blood-brain disposition and antinociceptive effects of d-penicillamine2,5-enkephalin in the mouse. J Pharmacol Exp Ther 283:1151–1159
Chen C, Pollack GM (1998) Altered disposition and antinociception of (d-penicillamine(2,5)) enkephalin in mdr1a-gene-deficient mice. J Pharmacol Exp Ther 287:545–552
Bauer B, Yang X, Hartz AM et al (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 70:1212–1219
Ouellet DM, Pollack GM (1995) A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats. J Pharmacokinet Biopharm 23:531–549
Ouellet DM, Pollack GM (1997) Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats. J Pharmacol Exp Ther 281:713–720
Heinzen EL, Pollack GM (2004) Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance development. Brain Res 1023:175–184
Heinzen EL, Pollack GM (2004) The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem Pharmacol 67:735–741
Stamler JS, Feelisch M (1996) Methods in nitric oxide research. Wiley, New York
Bush MA, Pollack GM (2000) Pharmacokinetics and protein binding of the selective neuronal nitric oxide synthase inhibitor 7-nitroindazole. Biopharm Drug Dispos 21:221–228
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
Colin A-K (1988) Microdialysis user’s guide, 4th edn. Carnegie Medicin, Stockholm
Maragos CM, Morley D, Wink DA et al (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242–3247
Fukuto JM, Hobbs AJ, Ignarro LJ (1993) Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem Biophys Res Commun 196:707–713
Lee S-C, Wang J-J, Ho S-T et al (1997) Nalbuphine coadministered with morphine prevents tolerance and dependence. Anesth Analg 84:810–815
Chen SW, Maguire PA, Davies MF et al (1996) Evidence for mu1-opioid receptor involvement in fentanyl-mediated respiratory depression. Eur J Pharmacol 312:241–244
Roy S, Liu HC, Loh HH (1998) mu-opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res Mol Brain Res 56:281–283
Culpepper-Morgan JA, Holt PR, LaRoche D et al (1995) Orally administered opioid antagonists. Neurosci Lett 56:1187–1192
Bourne JA (2003) Intracerebral microdialysis: 30 years as a tool for the neuroscientist. Clin Exp Pharmacol Physiol 30:16–24
Cano-Cebrián MJ, Zornoza T, Polache A et al (2005) Quantitative in vivo microdialysis in pharmacokinetic studies: some reminders. Curr Drug Metab 6:83–90
Heinzen EL, Booth RG, Pollack GM (2005) Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor. Biochem Pharmacol 69:679–688
Heinzen EL, Pollack GM (2003) Pharmacokinetics and pharmacodynamics of L-arginine in rats: a model of stimulated neuronal nitric oxide synthesis. Brain Res 989:67–75
Bush MA, Pollack GM (2001) Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in the rat hippocampus. Pharm Res 18:1607–1612
Heinzen EL, Pollack GM (2002) Use of an electrochemical nitric oxide sensor to detect neuronal nitric oxide production in conscious, unrestrained rats. J Pharmacol Toxicol Methods 48:139–146
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pollack, G.M. (2013). Indirect Analysis of Nitric Oxide and Quantitation of Selective Nitric Oxide Synthase Inhibitors in Microdialysate Samples. In: Di Giovanni, G., Di Matteo, V. (eds) Microdialysis Techniques in Neuroscience. Neuromethods, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-173-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-62703-173-8_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-172-1
Online ISBN: 978-1-62703-173-8
eBook Packages: Springer Protocols